STING1 and melanoma: In addition, activation of the STING pathway augments the antigenicity and recognition of human melanoma cells by tumor-infiltrating lymphocytes (TILs), while loss of STING or cGAS in tumor cells decreases T cell infiltration and response to checkpoint blockade in mismatch repair–deficient tumors (9–11).